A detailed history of Heartwood Wealth Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Heartwood Wealth Advisors LLC holds 244 shares of LLY stock, worth $182,514. This represents 0.02% of its overall portfolio holdings.

Number of Shares
244
Previous 287 14.98%
Holding current value
$182,514
Previous $259,000 16.6%
% of portfolio
0.02%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$772.14 - $960.02 $33,202 - $41,280
-43 Reduced 14.98%
244 $216,000
Q1 2024

Apr 02, 2024

BUY
$592.2 - $792.28 $169,961 - $227,384
287 New
287 $223,000
Q2 2023

Jul 19, 2023

BUY
$350.74 - $468.98 $311,106 - $415,985
887 New
887 $415,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Heartwood Wealth Advisors LLC Portfolio

Follow Heartwood Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartwood Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Heartwood Wealth Advisors LLC with notifications on news.